Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Gross Margin (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Gross Margin of 50.83% for Q2 2026, up 1.24 percentage points from 49.59% a year earlier and up 9.74 percentage points from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Gross Margin (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Amphastar Pharmaceuticals was 47.68%, down 2.18 percentage points year-over-year; for FY2025, it came in at 49.46%, down 1.62 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of +8.49 percentage points (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Gross Margin was 51.08% in FY2024 (-3.41 pp), 54.49% in FY2023 (+4.62 pp), 49.87% in FY2022 (+4.25 pp) and 45.63% in FY2021 (+4.65 pp).
  • Quarterly Gross Margin has run from a low of 41.08% in Q1 2026 to a high of 60.04% in Q3 2023 over five years.
  • On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of -3.56 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2023, with a gain of 11.33 percentage points; the weakest was Q1 2026, with a drop of 8.91 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 41.08% (Q1 2026), 46.79% (Q4 2025) and 51.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 50.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.83%
Mar 31, 2026 41.08%
Dec 31, 2025 46.79%
Sep 30, 2025 51.42%
Jun 30, 2025 49.59%
Mar 31, 2025 49.99%
Dec 31, 2024 46.45%
Sep 30, 2024 53.31%
Jun 30, 2024 52.18%
Mar 31, 2024 52.43%
Dec 31, 2023 53.98%
Sep 30, 2023 60.04%
Jun 30, 2023 49.92%
Mar 31, 2023 52.73%
Dec 31, 2022 52.71%
Sep 30, 2022 48.71%
Jun 30, 2022 51.31%
Mar 31, 2022 46.38%
Dec 31, 2021 46.52%
Sep 30, 2021 45.62%
API Access

Amphastar Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEY